Disease management. The industry's biggest priority, and its weakest spot. It's a no-brainer to make money (or save it) off people who want to live well.  One advantage in starting a new business to serve the employed and the incentivized, is that your customer base self-selects for those most likely to help you succeed (this doesn't mean you will succeed, but it sure helps a lot.) Acute care makes for medicine's shining moments; an area with comparatively discrete problems, when it comes to innovation and strategy, there are also usually easier to solve. Keeping the unwell from getting worse is a not only a Sysiphean task, its unlikely ever to be glamorous. This is why entrepreneurs flock to genomics or chronic disease prevention, but tend to leave the unattractive stuff of diabetes-day-to-day to patient run social networks, under the noble banner of self-care. (We have one startup that defies the stereotype; it addresses diabetes ulcers.) Kennedy "is someone to watch," peers say for things like Life 2. HMC, the disease management of massive WellPoint, claims service to more than 34 million people now and Kennedy's returns are impressive: $110 million in savings in her three years there. We admire her for stamina, too.  Before HMC, Kennedy ran or built disease management units for Empire Blue Shield (360° Health), CorSolutions,  and Oxford Health Plans. Heck, someone's gotta do it.